BGI customers to receive QIAGEN software


Tuesday, 05 May, 2015

QIAGEN and BGI have announced the expansion of their relationship, with QIAGEN’s Ingenuity Variant Analysis software to be provided to customers of BGI’s sequencing services.

Under the reseller agreement, BGI customers will receive sequencing data generated from their samples through Ingenuity Variant Analysis’s secure, cloud-based environment and gain access to its comprehensive gene variant data and genomic interpretation applications. The software will be provided by BGI to customers in China, Hong Kong and Taiwan, with plans to expand to other regions throughout the year.

“We welcome this opportunity to expand our relationship with QIAGEN for the benefit of BGI collaborators around the world,” said BGI Chief Scientist Yingrui Li. “Coupling BGI’s world-class sequencing with the deep bioinformatics of Ingenuity Variant Analysis will give researchers an enhanced, integrated way to seamlessly move quickly from raw data to valuable insights.”

The software quickly filters genetic variants in a cloud-based environment to identify variants most likely to cause disease. The product draws on the Ingenuity Knowledge Base, a repository of expertly curated biological interactions and functional annotations created from millions of individually modelled relationships between proteins, genes, complexes, cells, tissues, drugs and diseases.

“Integrating Ingenuity Variant Analysis into BGI’s highly reliable sequencing services will enable clients to accelerate workflows,” added Laura Furmanski, the head of QIAGEN’s Bioinformatics Business Area. “They’ll be able to transform large quantities of genomic data into valuable molecular insights for research or clinical applications.”

Related News

Australia to begin treaty negotiations on association to Horizon Europe

To give Australian organisations access to the world's largest pooled research fund in 2027,...

Vaxxas partners with AI company Profenso to support quality assurance

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in...

SA Police seize 'clandestine laboratory' drug-making equipment

Following a search at Woodville North last week, Western District Police have made one of the...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd